跳转至内容
Merck

332607

Sigma-Aldrich

(2-羟丙基)-β-环糊精

average Mw ~1,460

别名:

(2-羟丙基)-β-环糊精, HP-β-CD

登录查看公司和协议定价


About This Item

EC號碼:
分類程式碼代碼:
12352201
PubChem物質ID:
NACRES:
NA.22

形狀

powder

光學活性

[α]25/D +135°, c = 1 in H2O (typical)

分子量

average Mw ~1,460

標籤範圍

0.8 molar substitution

mp

267 °C (dec.)

SMILES 字串

CC(O)COCC1OC2OC3C(COCC(C)O)OC(OC4C(COCC(C)O)OC(OC5C(COCC(C)O)OC(OC6C(COCC(C)O)OC(OC7C(COCC(C)O)OC(OC8C(COCC(C)O)OC(OC1C(OCC(C)O)C2OCC(C)O)C(OCC(C)O)C8OCC(C)O)C(OCC(C)O)C7OCC(C)O)C(OCC(C)O)C6OCC(C)O)C(OCC(C)O)C5OCC(C)O)C(OCC(C)O)C4OCC(C)O)C(OCC(C)O)C3OCC(C)O

InChI

1S/C63H112O42/c1-22(64)8-85-15-29-50-36(71)43(78)57(92-29)100-51-30(16-86-9-23(2)65)94-59(45(80)38(51)73)102-53-32(18-88-11-25(4)67)96-61(47(82)40(53)75)104-55-34(20-90-13-27(6)69)98-63(49(84)42(55)77)105-56-35(21-91-14-28(7)70)97-62(48(83)41(56)76)103-54-33(19-89-12-26(5)68)95-60(46(81)39(54)74)101-52-31(17-87-10-24(3)66)93-58(99-50)44(79)37(52)72/h22-84H,8-21H2,1-7H3/t22?,23?,24?,25?,26?,27?,28?,29-,30-,31?,32?,33?,34?,35?,36?,37-,38?,39-,40+,41+,42+,43?,44+,45?,46+,47+,48+,49+,50+,51+,52-,53-,54-,55-,56-,57+,58-,59+,60-,61-,62-,63-/m1/s1

InChI 密鑰

ODLHGICHYURWBS-RYJYQAAZSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

(2-羟丙基)-β-环糊精是一种羟烷基衍生物,经证可作为一种制剂载体,增强药物在水溶液中的溶解度,从而将药物成功递送至生物系统。通常用作α-、β-和γ-环糊精的替代物。

應用

(2-羟丙基)-β-环糊精可用于:
  • 作为薄层色谱法(TLC)测定药物制剂中分析物的分析标准品。
  • 在使用反相高效液相色谱(RP-HPLC)定量之前,研究宿主-客体的有机低分子量化合物相互作用。
  • 作为HPLC法有效分离β-咔啉的流动相添加剂。
  • 环糊精修饰的胶束电动色谱(CD-modified MEKC)测定盐酸舍曲林及与合成相关产物。

亲脂性药物的溶解度随着水溶液中的羟丙基-β-环糊精(HP-β-CD)浓度线性增加,这是因为HP-β-CD与药物形成了复合物。这种客体-宿主型复合物在药物与HP-β-CD的非极性空穴间形成,导致溶解度增强。HP-β-CD可用于制备与罗哌卡因(RVC)形成的包合物,以增加RVC溶解度,确保有效的药物递送。
亲脂性药物的溶解度随着水溶液中的羟丙基-β-环糊精(HBC)浓度线性增加,这是因为HBC与药物形成了复合物。这种客体-宿主型复合物在药物与HBC的非极性空穴间形成,导致溶解度增强。 可以将溶液冻干以产生易溶的粉末。 对家兔和小鼠无毒性。

儲存類別代碼

13 - Non Combustible Solids

水污染物質分類(WGK)

WGK 1

閃點(°F)

>752.0 °F

閃點(°C)

> 400 °C

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Chromatographic Separation and Purification of Novel Drug Excipient 2-Hydroxypropyl-beta-Cyclodextrin [J]
Yimin Z, et al.
Chinese Journal of Analytical Chemistry, 5 (2006)
Daniele R de Araujo et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 33(1), 60-71 (2007-11-27)
Ropivacaine (RVC) is an enantiomerically pure local anesthetic (LA) largely used in surgical procedures, which presents physico-chemical and therapeutic properties similar to those of bupivacaine (BPV), but associated to less systemic toxicity. This study focuses on the development and pharmacological
Björn-Hendrik Peters et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 95, 72-81 (2016-05-26)
Microscale freeze-drying makes rapid process cycles possible for early-stage formulation development. To investigate the effects of equipment scale and cooling rate on the solid state properties and the protein's secondary structure of a sample, three binary formulations of catalase were
K Miyake et al.
Pharmaceutical development and technology, 5(3), 399-407 (2000-08-10)
The object of this study was to enhance the solubility, dissolution rate, and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CyD). The interaction of rutin with cyclodextrins (CyDs) was evaluated by the solubility, and ultraviolet (UV) and circular dichroism
S E Lucangioli et al.
Journal of chromatography. A, 871(1-2), 207-215 (2000-03-29)
In this work development, optimization and validation of a cyclodextrin-modified micellar electrokinetic chromatography (CD-modified MEKC) method is proposed to resolve separation of the sertraline hydrochloride and synthesis-related substances. Sertraline hydrochloride, the cis-(1S,4S) enantiomer form, is used as an antidepressant therapeutic

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门